Industrial Products company Standard Glass Lining Technology announced Q2FY26 results Total Income: Rs 188 crore during Q2FY26, change 5.6% QoQ. EBITDA: Rs 34 crore during Q2FY26, change -1.8% QoQ. PAT: Rs 20 crore during Q2FY26, change -3.2% QoQ. Nageswara Rao Kandula, Managing Director, said: “Our second quarter demonstrates continued strong sales growth and healthy financial performance. More importantly, this period marks a transformation in our journey from Standard Glass Lining Technology Limited to the proposed Standard Engineering Technology Limited signifying our transition into a concept-to-commissioning precision engineering enterprise. The acquisitions of Scigenics and C2C Engineering strengthen our end-to-end capabilities and global relevance. We are confident that our unique integration of design, manufacturing and commissioning skills will propel us toward sustainable growth and long-term value creation for our investors, customers and all stakeholders.” Result PDF
Industrial Products company Standard Glass Lining Technology announced Q1FY26 results Total Income stood at Rs 178 crore, registering a 23.6% YoY growth. EBITDA came in at Rs 35 crore, up 31.9% YoY, with an EBITDA margin of 19.5%. Profit Before Tax (PBT) is Rs 28 crore, reflecting a 39.6% YoY increase. Profit After Tax (PAT) is at Rs 21 crore, up 37.6% YoY, with a PAT margin of 11.9%. Nageswara Rao Kandula, Managing Director, said: “We are pleased with our continue healthy performance this quarter, which reflects our unwavering commitment to our customers, investors and all stakeholders. Through improved execution, we have delivered good margins while also expanding our exports and establishing our global footprint. Our focus on innovation has enhanced our reputation with customers, and our new offerings are gaining acceptance and appreciation. We remain confident that our efforts in technology development, product diversification, and international market expansion will open new avenues for sustainable, long-term growth. We also believe that the rapid growth of the CDMO business in India presents a significant opportunity for the Indian engineering industry. As global pharma and chemical companies increasingly turn to India for high-quality, cost-effective manufacturing solutions, we are wellpositioned to benefit from this trend—thanks to our strong customer relationships, proven execution capabilities, and engineering excellence.” Result PDF